Gossamer Bio, Inc.

GOSS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$48-$38-$37-$33
Dep. & Amort.$0$0$0$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$3$0$5
Change in WC$3-$10-$3-$6
Other Non-Cash$9-$2-$0-$3
Operating Cash Flow-$36-$47-$40-$35
Investing Activities
PP&E Inv.$0-$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$30-$76-$101-$84
Inv. Sales/Matur.$47$120$123$137
Other Inv. Act.$0$0$0$0
Investing Cash Flow$17$44$22$53
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$2$0$1$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$2$0$1$0
Forex Effect-$0$0$0-$0
Net Chg. in Cash-$17-$3-$17$18
Supplemental Information
Beg. Cash$26$29$46$28
End Cash$9$26$29$46
Free Cash Flow-$36-$47-$40-$35
Gossamer Bio, Inc. (GOSS) Financial Statements & Key Stats | AlphaPilot